使用欧梅普拉与法莫蒂丁对移植功能的影响:一项随机对照性研究
Miłosz Miedziaszczyk1,2, Marek Karczewski3, Ilona Idasiak-Piechocka3
1Department of General and Transplant Surgery, Poznan University of Medical Sciences, 61-701, Poznan, Poland. m.miedziaszczyk@wp.pl.
Scientific reports
|January 13, 2025
概括
在一年后的移植患者中,欧美普拉会增加塔克罗利血度,而欧美普拉和法莫蒂丁都不会影响移植功能. 在三年内,在两组中都观察到塔克罗利斯的剂量减少.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學.
- 移植医学 移植医学
背景情况:
- 塔克罗利斯是一种关键的免疫抑制剂,由细胞P450酶 (CYP3A4,CYP3A5) 代谢.
- 奥梅普拉抑制CYP2C19,CYP3A4和CYP3A5,而法莫蒂丁与这些酶没有显著的相互作用.
- 了解药物相互作用对于优化免疫抑制和移植后患者结果至关重要.
研究的目的:
- 为了比较奥梅普拉与法莫蒂丁对塔克罗利血度的影响.
- 为了评估梅和famotidine对接受tacrolimus的患者移植功能的影响.
主要方法:
- 一项随机研究涉及24名成年移植接受者,接受三重免疫抑制.
- 患者每天接受奥梅普拉 (20毫克) 或法莫蒂丁 (20毫克) 两种药物.
- 血中塔克罗利莫斯度和功能标志物被监测了三年.
主要成果:
- 一年后,阿梅普拉组的塔克罗利斯度显著增加 (p=0.0478).
- 在omeprazole (p=0.0440) 和 famotidine (p=0.0051) 两组中,塔克罗利斯剂量在第三年减少.
- 三年后,两组之间没有观察到膜过率百分比变化的显著差异,这表明对功能没有不良影响.
结论:
- 奥梅普拉显著改变了移植患者的塔克罗利血度.
- 欧梅普拉和法莫蒂丁都没有对移植脏的功能产生负面影响.
- 可能需要进一步的研究来控制与梅醇等CYP3A4/5抑制剂联合使用时的塔克罗利斯水平.
相关概念视频
01:11Renal Failure: Dose Adjustments
62
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
62
01:33Hormonal Regulation
32.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.9K
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
404
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
404
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
167
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
167
01:45Kidney Structure
68.7K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
68.7K